Free Trial

VCI Wealth Management LLC Purchases New Position in DaVita Inc. (NYSE:DVA)

DaVita logo with Medical background

VCI Wealth Management LLC purchased a new stake in shares of DaVita Inc. (NYSE:DVA - Free Report) in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 4,252 shares of the company's stock, valued at approximately $650,000.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in DVA. Wealth Quarterback LLC purchased a new stake in DaVita during the first quarter valued at approximately $765,000. AustralianSuper Pty Ltd purchased a new stake in DaVita during the first quarter valued at approximately $10,763,000. Impact Partnership Wealth LLC raised its position in DaVita by 21.7% during the first quarter. Impact Partnership Wealth LLC now owns 2,363 shares of the company's stock valued at $361,000 after purchasing an additional 422 shares during the period. Victory Capital Management Inc. raised its holdings in shares of DaVita by 31.9% in the first quarter. Victory Capital Management Inc. now owns 57,074 shares of the company's stock worth $8,731,000 after buying an additional 13,802 shares during the period. Finally, Kesler Norman & Wride LLC raised its holdings in shares of DaVita by 15.8% in the first quarter. Kesler Norman & Wride LLC now owns 5,643 shares of the company's stock worth $864,000 after buying an additional 769 shares during the period. 90.12% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several research analysts have commented on the company. Truist Financial reduced their price objective on DaVita from $170.00 to $164.00 and set a "hold" rating on the stock in a report on Monday, May 19th. Wall Street Zen upgraded DaVita from a "hold" rating to a "buy" rating in a report on Friday, April 25th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus target price of $164.50.

Read Our Latest Research Report on DaVita

DaVita Stock Up 3.0%

NYSE DVA traded up $4.20 during midday trading on Tuesday, hitting $143.63. 225,124 shares of the company traded hands, compared to its average volume of 807,903. The company has a debt-to-equity ratio of 23.18, a current ratio of 1.25 and a quick ratio of 1.20. The company has a market cap of $10.84 billion, a PE ratio of 14.21, a price-to-earnings-growth ratio of 0.97 and a beta of 1.11. The company's 50-day simple moving average is $140.11 and its 200-day simple moving average is $148.56. DaVita Inc. has a 52 week low of $131.76 and a 52 week high of $179.60.

DaVita (NYSE:DVA - Get Free Report) last posted its quarterly earnings data on Monday, May 12th. The company reported $2.00 earnings per share for the quarter, topping analysts' consensus estimates of $1.75 by $0.25. The firm had revenue of $3.22 billion during the quarter, compared to analysts' expectations of $3.22 billion. DaVita had a return on equity of 176.11% and a net margin of 6.63%. The business's quarterly revenue was up 5.0% on a year-over-year basis. During the same quarter last year, the firm earned $2.26 EPS. As a group, equities research analysts forecast that DaVita Inc. will post 10.76 earnings per share for the current year.

DaVita Company Profile

(Free Report)

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.

Featured Articles

Want to see what other hedge funds are holding DVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DaVita Inc. (NYSE:DVA - Free Report).

Institutional Ownership by Quarter for DaVita (NYSE:DVA)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in DaVita Right Now?

Before you consider DaVita, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DaVita wasn't on the list.

While DaVita currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

AI Stocks Are Printing Money — These 3 Are Just Getting Started
Why Drone Stocks Are Skyrocketing Right Now!
Pelosi Makes Big Bet on Broadcom—Here’s Why It Matters

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines